Medline Inc.
MDLN
$34.05
-$0.64-1.85%
NASDAQ
| 06/27/2026 | 03/28/2026 | 12/31/2025 | 09/27/2025 | 06/28/2025 | |
|---|---|---|---|---|---|
| Revenue | 11.60% | 10.66% | 14.78% | 11.38% | 11.33% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.60% | 10.66% | 14.78% | 11.38% | 11.33% |
| Cost of Revenue | 9.82% | 14.34% | 19.06% | 13.15% | 10.13% |
| Gross Profit | 16.27% | 0.93% | 3.40% | 6.72% | 14.62% |
| SG&A Expenses | 19.24% | 12.76% | 8.68% | 12.96% | 11.27% |
| Depreciation & Amortization | 0.57% | 0.57% | -0.56% | 2.31% | 4.76% |
| Other Operating Expenses | 2,385.71% | 87.50% | 87.50% | -63.64% | 600.00% |
| Total Operating Expenses | 16.51% | 13.76% | 16.76% | 12.50% | 10.37% |
| Operating Income | -37.20% | -23.55% | -10.32% | 0.00% | 21.90% |
| Income Before Tax | -34.54% | -13.91% | -32.46% | 2.07% | 19.67% |
| Income Tax Expenses | 269.23% | 225.00% | 62.50% | 64.29% | 225.00% |
| Earnings from Continuing Operations | -58.26% | -25.78% | -37.72% | -0.62% | 14.04% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -81.98% | -59.94% | -37.02% | -0.62% | 14.04% |
| EBIT | -37.20% | -23.55% | -10.32% | 0.00% | 21.90% |
| EBITDA | -25.94% | -15.39% | -5.76% | 0.61% | 16.58% |
| EPS Basic | 262.63% | 920.00% | 1,261.82% | -- | -- |
| Normalized Basic EPS | 538.71% | -- | 1,858.18% | -- | -- |
| EPS Diluted | 262.63% | 881.82% | 1,261.82% | -- | -- |
| Normalized Diluted EPS | 535.48% | -- | 1,858.18% | -- | -- |
| Average Basic Shares Outstanding | -95.11% | -- | -95.36% | -- | -- |
| Average Diluted Shares Outstanding | -95.08% | -95.28% | -95.36% | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -0.89% | 1.85% | 3.54% |